'''Tilomisole''' ('''WY-18,251''') is an experimental drug which acts as an [[immunomodulator]] and has been studied for the treatment of some forms of cancer.<ref name="pmid6970786">{{cite journal |vauthors=Fenichel RL, Alburn HE, Schreck PA, Bloom R, Gregory FJ |title=Immunomodulating and antimetastatic activity of 3-(p-chlorophenyl) thiazolo[3,2-a]benzimidazole-2-acetic acid (Wy-18,251, NSC 310633) |journal=Journal of Immunopharmacology |volume=2 |issue=4 |pages=491–508 |year=1980 |pmid=6970786 |doi= |url=}}</ref><ref name="pmid1385709">{{cite journal |vauthors=Dillman RO, Ryan KP, Dillman JB, Shawler DL, Maguire R |title=WY 18,251 (Tilomisole), an analog of levamisole: tolerability, and immune modulating effects in cancer patients |journal=Molecular Biotherapy |volume=4 |issue=1 |pages=10–4 |date=March 1992 |pmid=1385709 |doi= |url=}}</ref> 
